A tumor‐targeting nanomedicine carrying the p53 gene crosses the blood–brain barrier and enhances anti‐PD‐1 immunotherapy in mouse models of glioblastoma
Sang Soo Kim(Georgetown University Medical Center), Esther H. Chang(Georgetown University)
Cited by 65
Related Papers
Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide
|Nucleic Acids Research|2017|123
SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors
|International Journal of Nanomedicine|2024|6